The innate immune system relies on the recognition of pathogens by pattern recognition receptors as a role of Nod (nucleotide-binding oligimerization domain)-like receptors and AIM2 (absent in melanoma 2) as pattern and induction of pyroptosis. This paper summarizes recent developments regarding the function of Nod-like receptors in immunity and disease.
cytokines and chemokines that act on the surrounding tissue cells, as well as by up-regulation of adhesion and co-stimulatory molecules to promote recruitment of immune cells into the infected tissue. Two of these defense and are responsible for perpetuating this 10 IL-1 II.
AND IL-18: TWO CASPASE-1-DE-PENDENT PRO-INFLAMMATORY CYTOKINES
The processes that generate the biologically active -nism. In contrast to most cytokines, which are only transcriptionally induced and immediately secreted of TLRs, RLRs, and other PRRs that induce the in--vated B cells) and MAPK (mitogen-activated protein kinase) signaling pathways that collectively promote for the up-regulation of IL1B transcripts. In contrast, the IL18 transcript is constitutively produced in most cell types. Transcription/translation, however, only produces the intracellular, inactive precursors, pro--vation of caspase-1. Active caspase-1 proteolytically cleaves the prodomain to liberate the 17-and 18-kDa mature cytokines, which are then released by an atypical, leader peptide-independent mechanism, which is still controversial. [11] [12] [13] This caspase-1-dependency of to monocytes and macrophages. While monocytes express constitutively active
INTRODUCTION I.
In addition to the mechanical barrier of the skin, mammals are protected by two arms of the immune system, the innate and the adaptive immune systems, which cooperatively function to eradicate invading pathogens. The innate immune system is responsible for initial defense and also activates the adaptive -cess is the discrimination between self and non-self line-encoded pattern recognition receptors (PRRs) of innate immune cells sense pathogens directly at the infection site through recognition of pathogenassociated molecular patterns (PAMPs), which are conserved, and essential structures that are present on microorganisms but absent on host cells.
1 PRRs -rectly bind pathogens and mediate their internalization, and sensor PRRs, which respond to recognition pathways.
2 Sensor PRRs, such as the membranebound Toll-like receptors (TLRs) recognize PAMPs on the cell surface and lumen of endosomes and lysosomes. 3 More recently, PRRs that sense the cytosolic presence of PAMPs have been discovered, and these include the RIG-1 (retinoic acid-inducible gene-1)-like receptors (RLRs), 4 the nucleotide-binding and oligomerization domain (Nod)-like receptors (NLRs), [5] [6] [7] [8] and AIM2 (absent in melanoma-2).
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Macrophages also express a number of phagocytic PRRs, including scavenger receptors, C-type lectins, collectins, and pentraxins. 2 The broad activity of the innate immune system is provided by phagocytes such as monocytes, macrophages, neutrophils, dendritic cells, and epithelial cells, which engulf response. This response is mediated by the release of from short-lived and damaged cells. 15 and IL-18 are recognized by their receptors, IL-1RI -complex with the IL-1R accessory protein (IL-1RAc 10 Signal transduction is then mediated by the TIR (Toll/IL-1 receptor) domain, which is also present in TLRs, further emphasizing their link to innate immunity. Furthermore, both cytokines have a naturally occurring inhibitor, the IL-1R antagonist (IL-1Ra) and the IL-18 binding protein (IL-18BP), respectively.
In addition to its well-established role in matur--plicated in unconventional protein secretion extending beyond cytokine release. 16 Caspase-1 is able to also promote cell survival in response to microbial pore-forming toxins, which activate NLRP3 (NLR containing a PYD-3) and NLRC4 (NLR containing metabolic pathways to mediate membrane biogenesis and repair. 17, 18 In this capacity, caspase-1 activates the sterol regulatory element-binding proteins (SREBPs) 1 and 2, which in turn facilitate fatty acid metabolism and cholesterol and lipid biosynthesis. 19 This might appear to contradict the better known role of death called pyroptosis, which causes loss of plasma [20] [21] [22] [23] [24] However, morphologically, pyroptosis is reminiscent of death, which is NLRP3, ASC (apoptosis-associated speck-like protein containing a CARD), and cathepsin B dependent, but independent of caspase-1. 25, 26 depend on the state of the infection. While maturation the spread of a pathogen, the activation of membrane biogenesis could repair damage resulting from the microbial insult. There is now evidence that active caspase-1 is rapidly released from macrophages, which might prevent it from causing any further cell damage. 27 However, if the infection persists and cannot be cleared, caspase-1 is capable of inducing pyroptosis to eliminate the pathogen through cell death.
caspase-4, caspase-5 (and their mouse paralogue, caspase-11), and caspase -12. 28 caspases belong to the initiator caspases and contain a CARD as their pro-domain. Caspases are initially synthesized as inactive precursor proteins (zymogens) CARD is essential for the clustering of two or more -tivation by the induced proximity mechanism. 29 The clustering of pro-caspases occurs in large protein -
27

INFLAMMASOMES: PROTEIN PLATFORMS III. TO ACTIVATE INFLAMMATORY CASPASES
While the activation of TLRs, RLRs, and some NLRs initiates signaling cascades that ultimately promote a transcriptional response to up-regulate -al NLRs and AIM2 causes the formation and activaincluding caspase-1 and caspase-5, by the induced proximity mechanism.
27 For most characterized pro-caspase-1 activation. 30, 31 It binds to the CARDcontaining pro-domain of caspase-1 to mediate its oligomerization. Accordingly, enforced oligomeriza- 27, [32] [33] [34] Therefore, ASC and caspase-1 are shifted into a high-molecular-weight protein complex following in vitro activation. ASC is the adaptor to bridge ac-NLRP1 and caspase-5 are shifted into these largemolecular-weight complexes in response to in vitro activation. 27 However, in response to MDP (muramyl dipeptide) activation of macrophages in vivo, only NLRP1, Nod2, and caspase-1 are shifted into high-molecular-weight complexes. 35 Consistently, in vitro reconstituted NLRP1 in--masome activity. 36 In contrast to this ASC-inde--munodepletion of ASC is able to abrogate NLRP1 cell line THP-1 in response to lipopolysaccharide, which is reminiscent of the best-studied NLRP3 27 ASC directly interacts with NLRP3 by a PYD-PYD interaction, and recruits pro-caspase-1 by a CARD-CARD interaction. 34, 37 in spite of the direct interaction of NLRC4 with pro-caspase-1 by a CARD-CARD interaction. masome activation, which is most likely explained by their ability to heterodimerize. 35, 55 However, NLRP3, although NLRP3 has also been linked to 35, 50, 56 In addition to MDP, Nlrp1 is involved in sensing infections. The lethal toxin (LeTx) is responsible for mortality in systemic anthrax infections; inbred mice show a variable degree of sensitivity to LeTx, and this trait has been mapped to Nlrp1b. 57 LeTx activation of Nlrp1b depends on lysosomal membrane destabilization.
58 Similar to and Nod2, indicating that NLRP1/Nod2 heterodimers might be more prevalent. 35 It is still not known if MDP or LeTx are directly bound by NLRP1 or Nod2, but in a minimal in vitro reconstitution system NLRP1 is still able to respond to MDP, which suggests that MDP could be directly recognized.
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LeTx, on the other hand, causes macrophage death macrophage survival, through up-regulation of the caspase-1 inhibitor PAI-2 (plasminogen activator inhibitor-2).
59-61 Thus, it is more likely that LeTx is rather indirectly recognized by NLRP1/Nod2. As proposed for NLRP1, the Nod2 LRRs also engage with the CARD-NACHT region by intramolecular interaction, and this autoinhibitory interaction is reversed by MDP.
35,36
NLRP2 B.
NLRP2 (also known as NALP2, PYPAF2, NBS1, PAN1, and CLR19.9) interacts with ASC to form known as TUCAN and CARD8) (Figs. 1 & 2) . 37, 62 Cardinal is a FIIND and CARD-containing protein that can interact with caspase-1. 63 The interaction of Cardinal with NLRP2 occurs via the NACHT and or deletion of the LRR (which can activate NLRs), but does not interact with full-length naive protein, due to its inactive conformation. 37 Cardinal might provide the FIIND-CARD that is also present in NLRP1, but lacks in other NLRs, including NLRP2. However, unlike NLRP1, this interaction is insuf-37 While cell -lar to NLRP1 and NLRP3, the physiological NLRP2 agonist is still elusive.
NLRP3 C.
NLRP3 (also known as cryopyrin, cold-induced PYPAF1, and CLR1.1) is perhaps the best-studied caspase-1 (Figs. 1 & 2) . 30 Like NLRP2, NLRP3 in--sive, given the fact that it is absent from the mouse genome. 37 The interaction with ASC is induced by enforced NLRP3 oligomerization, which occurs upon ligand binding or upon expression of diseaseassociated mutations in the NLRP3 protein, indicatconstitutively active and uncoupled from ligand sensing.
42 Accordingly, disease-associated NLRP3 mutants cause enhanced oligomerization of ASC.
64
Because the LRRs are the ligand-sensing/-binding domain and keep the NLR inactive, deletion of the LRR renders the protein constitutively active.
42
NLRP3 came from macrophages isolated from NLRP3 is activated by a large number of diverse agonists, including PAMPs, DAMPs (danger-associated molecular patterns), pathogens, and synthetic damage, and/or reactive oxygen species (ROS) generation. 18, 40, 65, 66 PAMPs and other exogenous ligands that are recognized by NLRP3 include MDP, viral and bacterial dsRNA, poly(I:C), or the imidazo-ATP. 56, 65, 67, 68 The precise mechanism of how diverse PAMPs activate NLRP3 is not clear, but potentially promotes macrophage priming to up-regulate pro--ration. Activation and opening of the pannexin-1 channel may allow entry of PAMPs into the cytosol. In fact, pannexin-1 channel opening occurs as a con- 58 The same study also pointed out that CA-074Me, a previously LeTx-induced Nlrp1b activation independently from acting on cathepsin B through inhibiting alternative protease activity induced or released by lysosomal membrane permeabilization. 58 The NLRP3-agonist role of such crystals can be mimicked by direct lysosomal rupture using pharmacological or mechanical mechanisms, which cause NLRP3 activation, supporting the essential role of lysosomal destabilization for NLRP3 activation. 81, 83, 90 NLRP3 is also responsible for sensing diverse pathogens, including the gram-positive bacteria S. C. albicans-mediated NLRP3 activation is independent of lysosomal damage and cathepsin B release, but dependent on ROS generation, which is in agreement with an essential role of Syk in the generation of ROS in response to fungal infections. 75, 102 Similarly, monosodium urate and other particulates that activate NLRP3 have been shown to activate Syk. Therefore, the generanot all, of the NLRP3 activators.
Further support for the importance of ROS comes from experiments with ROS scavengers such as N-acetyl cysteine. 70, 73, 75, 76, 85, 100 Recently, the link between ROS and NLRP3 has been elucidated. The LRRs of NLRP3, but not other NLRs, interact protein (TXNIP). While TXNIP is bound to TRX during homeostasis, elevated ROS levels induce the dissociation of TXNIP from TRX, allowing TXNIP to interact and activate NLRP3 in a ROS-dependent manner.
103 However, not all stimuli causing the generation of ROS also cause activation of NLRP3 and -lation downstream of ROS. Thus, there might be several distinct mechanisms responsible for NLRP3 activation, including ATP/P2X 7 R/pannexin-1/K + depletion, lysosomal destabilization and potentially release of proteases such as cathepsin B and L, and the generation of ROS.
NLRC4 and NLRB1 D.
NLRC4 (also known as CARD12, NOD27, CLAN, IPAF, and CLR2.1) is an NLR containing a CARD, which can directly recruit caspase-1, but also interacts with ASC (Figs. 1 & 2) . [104] [105] [106] Like Nod2, Nod1 (also known as NLRC1, CARD4, and CLR7.1) contains a CARD and has a well-charvia its adaptor RIP2 in protein platforms called nodosomes (Figs. 1 & 2) . 125, 126 Also similar to Nod2, Nod1 detects breakdown products from peptidoglygram-negative bacteria. 127, 128 There is very limited -masome activation. However, based on an overexpression study, Nod1 interacts with pro-caspase-1 by CARD interaction, causing its activation and matu-129 There is also indirect evidence for this interaction, since meso-diaminopimelic acid--relates with Nod1 expression in uveitis.
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NLRP12 F.
Little is known about NLRP12 (also known as Monarch-1, NALP12, PYPAF7, RNO2, PAN6, and 131-133 NLRP12 44 However, based on overexpression studies, NLRP12 can also interact -masome (Fig. 2) .
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AIM2 G.
AIM2 belongs to the HIN-200 (hematopoietic interferon-inducible nuclear protein with a 200-amino acid repeat; also known as p200 or PYHIN) family of interferon-response genes, which consists of four human (MNDA, IFI16, IFIX, and AIM2) and six mouse proteins, with AIM2 being the most conserved member.
134 HIN-200 proteins share a conserved domain architecture consisting of an N-terminal PYD (except p202a and p202b) and one or two copies of the HIN-200 domain (Figs. 1 & 2) . Although HIN-200 members were initially considered to be transcriptional regulators of cell proliferation and differentiation, it has been recently established that AIM2 functions as a PRR by directly binding to cytosolic double-stranded DNA (dsDNA). The DNA-binding capacity of the HIN-200 proteins was recognized early on, and is thought to be responsible for their multiple functions in transcriptional regulation. 135 As discussed above, L. monocytogenes is also sensed 123 also more susceptible to infection by F. tularensis, lack IL-18 production in response to mouse cytomegalovirus infection resulting in higher virus titers than controls.
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pyroptosis, and AIM2 -/-macrophages are protected from caspase-1-induced cell death. 122, 145 The dsDNA p202, another HIN-200 member, which has no human ortholog. Because p202 binds dsDNA similarly to AIM2 (p210), but lacks the PYD, it cannot interact blocks dsDNA-induced caspase-1 activation. Therefore which causes knockdown of p202, increasing caspase-1 activation in response to dsDNA.
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Pyrin H.
Pyrin is the founding member of the PYD family. Like AIM2, it has a different domain architecture from NLRs. It consists of a PYD, a central BBox/ Coiled Coil (CC), and a C-terminal PRY/SPRY domain (Figs. 1 & 2) . Pyrin interacts with several inactivation is still controversial. Evidence for its in-PSTPIP1 (proline serine threonine phosphatase-interacting protein 1), also known as cluster of differentiation-2 (CD2) binding protein-1 (CD2BP1). 146 This association is mediated by the BBox/CC in pyrin and by the SH3 (Src homology-3)/CC region in PSTPIP1, and is markedly increased in PSTPIP1 harboring pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome-associated mutations such as A230T and E250Q. 146 These PSTin monocytes. Pyrin can form ASC and caspase-1 -33,64,147 On endogenous level, PSTPIP1 binding to pyrin promotes the unmasking of its PYD and the interaction with ASC, to recruit caspase-1, which is enhanced by the presence of PSTPIP1 proteins harboring the PAPAlinked mutations.
148 Any pathogens or PAMPs that are potentially sensed by pyrin remain elusive.
Pyrin is transcriptionally up-regulated in re-149 Furthermore, type I interferons and retroviral infection induces expression of pyrin, raising the possibility that pyrin is involved in the antiviral host response. 148 Pyrin is also known as TRIM20 (tripartite motif-containing protein 20). Other TRIM family retroviral replication via SPRY domain-mediated viral capsid recognition. Furthermore, TRIM22 mediates its antiviral activity by directly interacting with the HIV core. [150] [151] [152] proteins comprised of NLRs and the SPRY of pyrin, further suggesting a role of pyrin in pattern recognifever (FMF)-linked mutations in pyrin are located inside the SPRY domain, further emphasizing the -masome activation.
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-antagonistic role of pyrin. Macrophages expressing a truncated pyrin protein retaining only the PYD express increased levels of active caspase-1 and are 154 The PYD of pyrin is still expressed in these cells. Because pyrin interacts with ASC through their PYDs to modulate downstream signaling pathways, expression of the pyrin-PYD could potentially affect 64, 155, 156 by the observation that knockdown of pyrin in the human THP-1 monocytic cell line augmented release - 157, 158 Mechanistically, pyrin interacts via its SPRY do--cluding the NACHT domains of NLRP1, NLRP2, and NLRP3; the caspase domain of caspase-1; and potentially complexes with these proteins to prevent their activation. Furthermore, the commonly FMFassociated pyrin mutations M694V and M680I impair the interaction of pyrin with caspase-1, thus providing a possible explanation for the excessive 158 However, in another study, knockdown of pyrin in the same THP-1 cell line and in primary human monothe limited pyrin expression in macrophages is the 147 In addition, pyrin itself is cleaved by caspase-1, and the N-terminal fragment comprised of the PYD and the bZIP (basic leucine zipper) domain activates This fragment directly interacts with p65 and potentially acts as a transcription factor, and it also --159 controversial and is likely to be dependent on the context of cellular activation.
NOD-LIKE RECEPTORS: LINK TO AUTOIN-V. FLAMMATORY AND AUTOIMMUNE DISEASES
nity, it is not surprising that excessive production of both cytokines is closely linked to an expanding -matory diseases.
160
-(tumor necrosis factor receptor-1)-associated periodic syndromes, 161 and has since been expanded to include an increasing number of self-directed characterized by the absence of high-titer autoanti--ited autoimmune origin. 162 The more details emerge evidence also points to a direct contribution of in-
FMF is a recessively inherited, prototypic autoinrecurrent episodes of fever, which can be asymptomatic or coincide with abdominal pain; signs of pain in the chest with pleuritis and pericarditis, myalgia, or erysipeloid; and elevated acute-phase reactions that can lead to secondary amyloidosis. 163 which was called MEFV (Mediterranean fever gene) and which encodes pyrin. 164, 165 There have been 193 hereditary mutations in MEFV linked to FMF, with that cluster in exon 2, which contains the bZIP, and exon 10, which contains PRY/SPRY (Fig. 2) . Fewer mutations are found in exon 3 (containing the BBox) and exon 5 (see Infevers, an online database for au-ISSAID/infevers). [166] [167] [168] As discussed above, the preand it is feasible that it has a dual physiological role.
then the recessively inherited FMF mutations could render the protein defective, causing a loss-of-func--tion of pyrin, then the dominant inherited FMF mutations could manifest as a gain-of-function phenotype. 169 Notably, some of the most common mutations are located inside the PRY/SPRY domain, including M694V, V726A, M680I, M694I, together with E148Q in exon 2, which account for more than 70% of all cases.
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plained by a positive selection mechanism, which possibly acts by conferring resistance to infection.
169
This hypothesis is supported by the observations that some of the FMF mutations inside the PRY/SPRY domain, including M680I and V726A, are found in wild-type primate alleles, indicating that some FMF mutations recapitulate an ancestral state and that primates might not be exposed to this putative pathogen.
171 Furthermore, the PRY/SPRY domain is missing in rodents, and therefore is a recent evolutionary development, further emphasizing a human-172 Several of the severe FMF mutations localize close to a putative binding pocket in the PRY/SPRY domain, suggesting that pyrin could potentially directly recognize a pathogen.
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NLRP3 B.
NLRP3, initially known as cryopyrin and encoded by the CIAS1 gene, was initially cloned based on its also known as familial cold urticaria or FCU) and Muckle-Wells syndrome (MWS) (Fig. 2) .
173 Sub--as chronic infantile neurological cutaneous and articular syndrome or CINCA). 174, 175 masome-linked disorders are now collectively referred to as cryopyrinopathies or CIAS1-associated periodic syndromes (CAPS), and are caused by autosomal dominant or de novo mutations in NLRP3, which are generally linked to excessive production 153 These disorders usually develop during childhood, and are characterized by unexplained episodes of fever and severe localized patients also display a deranged redox homeostasis, characterized by elevated ROS levels and thus partially explain the episodic nature of this disorder. 176 NOMID is characterized by recurrent episodes of fever, urticarial rash beginning in the neonatal period, chronic meningitis, uveitis, loss of hearing, and growth retardation.
177 FCAS displays recurrent episodes of rash, cold-induced urticaria, fever, arthralexposure.
177 MWS patients have fever, progressive loss of hearing, urticaria, arthralgia, and rare amyloidosis. 177 At least 120 mutations are described in NLRP3, although not all are clearly linked to cryopyrinopathies. Most of these mutations are located in exon 3, which encodes the NACHT domain and -otide substitutions.
166-168 NLRP3 mutations cause spontaneous oligomerization, recruitment of ASC, 42, 64 Recently, mouse models of cryopyrinopathies have been generated by introducing FCAS and MWS mutations (A350V and L351P, corresponding to humans A352V and L353P), or by using the shared R258W mutation (corresponding to human R260W) into Nlrp3, and also show a skewed Th17 response. 178, 179 Most importantly, the mutations --cantly higher sensitivity to TLR ligands and do not NLRP3 polymorphisms are also linked to a number of autoimmune conditions. Gout and pseudogout caused by deposition of monosodium urate and calcium pyrophosphate dihydrate crystals in articular and periarticular tissues. Monosodium urate is a danger -masome. 66 Cholesterol crystals are also recognized contributes to atherosclerosis in mice. 84 Fibrillar which is linked to the pathology of Alzheimer's dis- 83, 85, 86, 180 Schnitzler syndrome is a rare disease characterized by a chronic urticarial eruption and monoclonal gammopathy, and the symptoms include bone pain, fever, arthralgia, lymphadenopathy, leucocytosis, hepatomegaly and/or splenomegaly. NLRP3 (V198M) predisposes to Schnitzler syndrome and dysregulated -esis of Schnitzler syndrome. 181, 182 Crohn's disease is a multifactorial, chronic -lon and terminal ileum, which is characterized by -and polymorphisms in NLRP3 (Q705K) alone and in combination with Cardinal (C10X), contribute -ity to Chrohn's disease, and polymorphisms in -toid arthritis.
183-186 Two NLRP3 single-nucleotide polymorphisms (rs4612666 and rs10754558) are food allergy, food-induced anaphylaxis, and aspirin-induced asthma, and also predispose to type-1 diabetes and celiac disease, indicating that derailed multiple diseases, further emphasizing the central role of NLRP3.
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NLRP1 C.
Generalized vitiligo is a polygenic, multifactorial, non-contagious disorder that causes autoimmune loss of melanocytes and results in progressive loss of pigmentation from skin, overlying hair, and oral mucosa. Polymorphisms in NLRP1 predispose to generalized vitiligo and associated autoimmune diseases autoimmune thyroid disease, latent autoimmune diabetes in adults, rheumatoid arthritis, psoriasis, pernicious anemia, systemic lupus erythematosus, and Addison's disease (Fig. 2) . [189] [190] [191] [192] Polymorphisms are located within the promoter region and could affect transcription of NLRP1 or cause one amino acid substitution (L155H), but whether -rants further investigation.
NLRP2 D.
As discussed above, little is known about NLRP2--demann syndrome (BWS), a genetically complex congenital overgrowth syndrome, is a genomic imprinting disorder caused by mutation or altered expression of genes located in the imprinted 11p15.5 chromosomal region that are implicated in cell cycle and growth control, such as IGF2 (insulinlike growth factor-2), KCNQ1oT1 (potassium voltage-gated channel KQT-like subfamily member-1 (cyclin-dependent kinase inhibitor 1C). 193 A posi--gous frameshift mutation in exon 6 of NLRP2 in the mother of a BWS patient (Fig. 2) . 194 The frameshift c.1479delAG causes p.Arg493SerfsX32, resulting in a truncated protein lacking 539 amino acids encoding the LRR. The disturbed imprinting of BWS patients suggests a role of NLRP2 in establishing or maintaining genomic imprinting/methylation.
194
This scenario is intriguing, because methylation might have evolved as a transposon defense mechanism. However, BWS patients do not show any in- 194, 195 
NLRP7 E.
NLRP7 has been implicated in the regulation of caspase-1 activity based on one overexpression study. Therefore, information on its contribution, 196 Familial recurrent hydatidiform mole (FRHM) is an autosomal-recessive condition that results in abnormal human pregnancy with no embryo and hydropic degeneration of chorionic villi.
197 Like BWS, FRHM is a genomic imprinting disorder, thus linking a second NLR to imprinting defects. There have been 145 NLRP7 mutations described, and at least 23 hereditary mutations in NLRP7 have been -mozygous or compound heterozygous for NLRP7 mutations were shown to be at risk for reproductive wastage (Fig. 2) . [166] [167] [168] Several NLRP7 muta-NACHT of NLRP7. [198] [199] [200] [201] [202] [203] [204] [205] There is speculation that FRHM might result from an immune-related defect during oogenesis or early embryonic development, but there is no information about whether NLRP7 mutations could cause gain-of-function, similar to cryopyrinopathies, or loss-of-function, as shown for Nod2 mutations in Crohn's disease. NLRP7 after all, because NLRP7 has a role in cell proliferation, is up-regulated in testicular seminoma cells, and gene silencing of NLRP7 suppresses cell growth. 206 Expression levels of NLRP7 are also correlated with the myometrical invasion in endometrial cancer.
207
NLRP12 F.
role of NLRP12, but using a candidate gene approach, the NLRP12 gene in two families with a hereditary periodic fever syndromes referred to as Guadeloupe variant fever syndrome (FCAS2) (Fig. 2) .
208 FCAS2 causes clinical symptoms similar to those of FCAS and MWS, including cold-induced fever episodes, arthralgia, and myalgia. At least 25 mutations have been idena deletion of the LRRs, and R284X, which truncates the protein within the NACHT, are linked to FCAS2. 208 inhibition, but NLRP12 (c.2072+3insT) is also less po-208 -tivity is not known.
NLRB1 G.
Spinal muscular atropy (SMA) is an autosomal-recessive neuromuscular disease characterized by the degeneration of motor neurons in the spinal cord, which results in progressive weakness and wasting 209 Deletions and mutation of NLRB1 have been shown to cause SMA (Fig. 2 ).
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NOD1 and NOD2 H.
Autosomal dominant mutations in Nod2, mostly within the NACHT domain, are linked to Blau syndrome, which is characterized by granulomatous dermatitis, arthritis, and uveitis (Fig. 2) . 211 Blau syndrome-associated Nod2 mutations are gain-offunction mutations characterized by elevated NF--tral NACHT domain. [166] [167] [168] In addition, one of the and Nod2 mutations are linked to the susceptibility to Crohn's disease, which is characterized by diarrhea and abdominal pain. 212, 213 More than 77 mutations are linked to Crohn's disease and 24 to ulcerative colitis, which partially overlap with Crohn's disease; the most common ones are a frameshift mutation (c.L1007fsinsC) and substitutions within the LRR, such as R702W and G908R. 213 In con--tion phenotype.
214 The Crohn's disease phenotype could result from reduced epithelial cell barrier -paired growth restriction and clearance of invasive bacteria such as . [215] [216] [217] Accordingly, Crohn's disease-linked mutations show impaired 218, 219 However, macrophages engineered for Nod2 Crohn's disease -function mutation. 220 Nod1 polymorphisms are also linked to susceptibility to Crohn's disease (Fig.  2) . 221, 222 Seven gain-of-function Nod2 mutations are linked to early-onset sarcoidosis. 223, 224 Furthermore, the c.802C>T polymorphism is associated with chronic gastritis and predisposition to cancer in H. pylori-infected patients.
225,226
INFLAMMASOMES: A TARGET FOR THER-VI. APEUTIC INTERVENTION
(anakinra), IL-1TRAP (rilonacept), or humanized --inently the cryopyrinopathies, but are also effective in rheumatic diseases and psoriasis. [227] [228] [229] Based on the interaction of IL-1Ra with the IL-1RI, the small peptide antagonist peptide 101.1 was developed, -ease and phorbol 12-myristate 13-acetate-induced dermatitis mouse models. 230 Caspase-1 has also been directly targeted (pralnacasan and VX765), vivo despite some toxicity. 87, 231, 234 An adverse effect, as for any targeted biological anti-cytokine therapy, is that global cytokine blocking is linked to a slight increase in emerging opportunistic infections. 235, 236 Thus, a more targeted approach could be superior, Colchicine, a microtubule inhibitor, is a standard treatment for FMF and gout, which not only impairs neutrophil migration and cytokine production, but also blocks phagocytosis. 237 In addition, colchicine and nocodazole, another microtubule inhibitor, reduce the interaction of PSTPIP1 with pyrin to block pyrin-induced activation of caspase-1. 148 The type 2 diabetes drug glyburide (glibenclamide), which inhibits ATP-sensitive K + channels, blocks the acmechanism downstream of the P2X 7 R, and is the 238 Potentially, the pannexin peptide could be used to similarly block NLRP3 activation, although no in vivo application has yet been reported. 72 Increasing evidence points to an infor receptor function, whether this is modulation caspase-1 by NLRP1 and NLRP3. 36, 43, 44 Thus, one potentially could explore exploiting the ATP-bindtargeted therapy.
CONCLUSIONS VII.
The study of NLRs and related PRRs and the dis--dous insights into innate immunity and host defense over the past decade. They have also provided mo--enabled the availability of novel treatment opportunities, such as anakinra and its derivatives and the disease patients. However, there is still much room for further investigation, considering that we currently only have limited understanding of the nature of agonists initiating activation and of the physi- 
